Gene editing therapy for blood disorder recommended for NHS use
Hundreds of people in England with a life-limiting blood disorder are set to benefit from a world-first gene-editing therapy after it was given the green light for NHS use. Health bosses hailed the decision by the National Institute for Health and Care Excellence (Nice) as a “historic moment” for patients with the condition. Exagamglogene autotemcel, or exa-cel, is sold as Casgevy and made by Vertex. The treatment is the first […]